Peter Robert Galle

23PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMolecular targetsNuclear medicineRespiratory diseasesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 03, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

|Jan 09, 2025
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial).

Christian Fottner, Leonidas Apostolidis, Sebastian Krug

|Sep 11, 2024
Evaluation of Sonographic Muscle Measurement Using Established Muscle Markers.

Wolfgang Maximilian Kremer, Alexander Schwarz, Markus Schepers

|Mar 19, 2024
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2.

Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven

|Sep 27, 2023
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

|Mar 17, 2023
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis.

Simon J Gairing, Eva M Schleicher, Peter R Galle

Pageof 4

Frequent Collaborators

5 joint publications

Roman Kloeckner

5 joint publications

Masatoshi Kudo

4 joint publications

Christian Labenz

3 joint publications

Friedrich Foerster